Trial Profile
Safety of Xeloda in Solid Tumours
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2017
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel
- Indications Advanced breast cancer; Colon cancer
- Focus Adverse reactions
- Sponsors Roche
- 27 Jun 2015 New trial record